Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1498 | 7016 | 42.5 | 86% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
584 | 13283 | ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//HMGB1 |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
222 | 3830 | ADVANCED GLYCATION END PRODUCTS//GLYCATION//PENTOSIDINE |
4828 | 1647 | HMGB1//HIGH MOBILITY GROUP BOX 1//HIGH MOBILITY GROUP BOX 1 PROTEIN |
8648 | 1163 | RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE |
21012 | 376 | ETHYL PYRUVATE//CARDIAC STUNNING//ROLLING MEADOWS IL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | Author keyword | 534 | 51% | 11% | 758 |
2 | HMGB1 | Author keyword | 460 | 63% | 7% | 466 |
3 | RAGE | Author keyword | 358 | 58% | 6% | 418 |
4 | GLYCATION | Author keyword | 295 | 41% | 8% | 566 |
5 | HIGH MOBILITY GROUP BOX 1 | Author keyword | 210 | 65% | 3% | 198 |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | Author keyword | 175 | 68% | 2% | 155 |
7 | PENTOSIDINE | Author keyword | 116 | 57% | 2% | 137 |
8 | ADVANCED GLYCATION END PRODUCT | Author keyword | 111 | 58% | 2% | 128 |
9 | AGES | Author keyword | 106 | 44% | 3% | 183 |
10 | SRAGE | Author keyword | 104 | 73% | 1% | 79 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | 534 | 51% | 11% | 758 | Search ADVANCED+GLYCATION+END+PRODUCTS | Search ADVANCED+GLYCATION+END+PRODUCTS |
2 | HMGB1 | 460 | 63% | 7% | 466 | Search HMGB1 | Search HMGB1 |
3 | RAGE | 358 | 58% | 6% | 418 | Search RAGE | Search RAGE |
4 | GLYCATION | 295 | 41% | 8% | 566 | Search GLYCATION | Search GLYCATION |
5 | HIGH MOBILITY GROUP BOX 1 | 210 | 65% | 3% | 198 | Search HIGH+MOBILITY+GROUP+BOX+1 | Search HIGH+MOBILITY+GROUP+BOX+1 |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | 175 | 68% | 2% | 155 | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS |
7 | PENTOSIDINE | 116 | 57% | 2% | 137 | Search PENTOSIDINE | Search PENTOSIDINE |
8 | ADVANCED GLYCATION END PRODUCT | 111 | 58% | 2% | 128 | Search ADVANCED+GLYCATION+END+PRODUCT | Search ADVANCED+GLYCATION+END+PRODUCT |
9 | AGES | 106 | 44% | 3% | 183 | Search AGES | Search AGES |
10 | SRAGE | 104 | 73% | 1% | 79 | Search SRAGE | Search SRAGE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | END PRODUCTS | 608 | 48% | 13% | 929 |
2 | GLYCATION END PRODUCTS | 496 | 29% | 21% | 1453 |
3 | RAGE | 469 | 58% | 8% | 546 |
4 | MOBILITY GROUP BOX 1 | 461 | 65% | 6% | 443 |
5 | HMGB1 | 415 | 60% | 6% | 455 |
6 | N EPSILON CARBOXYMETHYLLYSINE | 277 | 69% | 3% | 239 |
7 | AMPHOTERIN | 276 | 83% | 2% | 156 |
8 | ADVANCED GLYCOSYLATION | 244 | 62% | 4% | 254 |
9 | CHROMATIN PROTEIN HMGB1 | 240 | 76% | 2% | 169 |
10 | MAILLARD REACTION | 228 | 27% | 10% | 731 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection | 2011 | 297 | 134 | 85% |
HMGB1 and RAGE in Inflammation and Cancer | 2010 | 398 | 142 | 68% |
AGEs and chronic subclinical inflammation in diabetes: disorders of immune system | 2015 | 4 | 97 | 71% |
Advanced glycation end products - Sparking the development of diabetic vascular injury | 2006 | 575 | 125 | 84% |
Biochemistry and molecular cell biology of diabetic complications | 2001 | 3580 | 92 | 33% |
HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease | 2012 | 112 | 80 | 78% |
Role of advanced glycation end products in cellular signaling | 2014 | 31 | 213 | 61% |
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis | 2013 | 51 | 55 | 75% |
The role of advanced glycation end products in progression and complications of diabetes | 2008 | 281 | 105 | 76% |
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal | 2005 | 973 | 121 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHROMATIN DYNAM UNIT | 57 | 95% | 0.3% | 19 |
2 | BIOCHEM MOL VASC BIOL | 52 | 65% | 0.7% | 50 |
3 | EXPT DIABET AGING | 34 | 54% | 0.6% | 44 |
4 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | 28 | 36% | 0.9% | 62 |
5 | CMRI | 16 | 34% | 0.6% | 39 |
6 | PATHOPHYSIOL SCI | 15 | 25% | 0.8% | 53 |
7 | AMREP PRECINCT | 8 | 75% | 0.1% | 6 |
8 | MED CLIN CHEM 1 | 7 | 25% | 0.4% | 26 |
9 | BIOL VASC CELLULAIRE | 7 | 53% | 0.1% | 9 |
10 | HUMAN NUTR HLTH GRP | 7 | 57% | 0.1% | 8 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000027181 | MAILLARD REACTION//MAILLARD REACTION PRODUCTS//FUROSINE |
2 | 0.0000024549 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF |
3 | 0.0000024157 | METHYLGLYOXAL//GLYOXALASE I//GLYOXALASE |
4 | 0.0000013145 | CARNOSINE//ANSERINE//CARNOSINASE |
5 | 0.0000012339 | NUCLEAR MATRIX//PROT SECT//MATRIX ATTACHMENT REGION |
6 | 0.0000008703 | METFORMIN//ACARBOSE//GLIMEPIRIDE |
7 | 0.0000008411 | ALPHA CRYSTALLIN//CATARACT//LENS |
8 | 0.0000008237 | LOX 1//OXIDIZED LDL//SCAVENGER RECEPTOR |
9 | 0.0000007733 | ALDOSE REDUCTASE//ALDO KETO REDUCTASE//17 BETA HYDROXYSTEROID DEHYDROGENASE |
10 | 0.0000007354 | DIABETIC NEUROPATHY//SYMPATHETIC SKIN RESPONSE//NERVE BLOOD FLOW |